0 results for 'Bristol-Myers Squibb Pharmaceuticals'
Securities Fraud Action Survives Against Waste Management Over Acquisition of Competitor
Plaintiffs Fail to Allege Bristol-Myers Squibb Defendants Acted with Requisite Scienter
Plaintiff Adequately Alleges Drug Company's Scienter Over Statements About FDA Approval
Big Law Squares Off in Battle Over Prescription Drug Prices
Courts have consistently rejected challenges under the Takings Clause to federal health care programs that seek to limit costs, according to an amicus curiae brief by a panel of nine nationally recognized experts in Medicare and medical finance.Deal Watch: Big Law Dealmakers Are Evaluating These Factors to Assess 2024 Market
Frank Aquila, partner in Sullivan & Cromwell's corporate group, said the tempering of inflation and the broader economic news that ushers in could be a boon for M&A in 2024.View more book results for the query "Bristol-Myers Squibb Pharmaceuticals"
Juror Attitudes Toward Pharmaceutical Companies
In February 2023, the DOAR Research Center sought to shed light on changing attitudes toward the pharmaceutical industry by conducting a survey, which questioned respondents on their opinions of the pharmaceutical industry and their COVID-19 experiences. This article highlights the results of the survey.Mayo Clinic, Lifepoint Claim Drugmakers Conspired to Delay Generic Competition for Chemo Drug
This suit was surfaced by Law.com Radar. Read the complaint here.Contaminant Bacterium Not Active, Inactive Ingredient Needing Disclosure, Warning Label
Jones Days Steps Into Fray as Big Pharma Battles Over Medicare Drug Prices
The suit claims the price negotiation program violates the Fifth Amendment bar on uncompensated takings and the First Amendment bar on compelled speech.Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now
Practical Guidance Journal: Protecting Work Product in a Generative AI World
Brought to you by LexisNexis®
Download Now
Countdown to Compliance: SEC Private Fund Reforms
Brought to you by Ontra
Download Now